BioinformaticsbioRxivPreprint
Integrated Blood Brain Transcriptomics Reveals CD79A and GRIA2 as Drug Repurposing Targets in Multiple Sclerosis
Mohamed A Mahmoud, Mohammed M. Alshehri
The paper identifies CD79A and GRIA2 as dual-compartment drug targets in MS by integrating PBMC and brain lesion transcriptomics with network analysis and molecular docking.
DOI 10.1101/2025.09.02.673787